This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bio-pharma Internal Communications Groups Evolving For Structure Optimization

CHAPEL HILL, N.C., March 22, 2013 /PRNewswire/ -- From Medical Affairs groups to brand teams conducting new product launches, Internal Communications groups within biopharmaceutical companies are constantly evolving to reflect the changing goals and strategies of the industry. Rearranging the structure of the group in order to support new corporate initiatives is a key change that executives must enforce in coming years. Across the bio-pharma sector, establishing service levels to reflect priorities and resources is essential for optimization of group effectiveness.

In order to fully understand the emerging needs of Internal Communication groups in the bio-pharma industry, Best Practices, LLC developed a benchmarking study. The primary research, "Internal Communications Excellence: Optimizing Group Structure & Operations," addresses current trends in external communications with respect to its structural models, staffing and investment levels.

Key insights from this study include:

  • Across the bio-pharma sector, outsourcing appears as a key tactic to manage variable issues and budgets.
  • Nearly 50 percent of pharma companies believe significant opportunities exist with key external partners to improve clarity of roles, responsibilities, performance metrics and annual planning.
  • Across industries, Internal Communications leaders clearly think the most effective approach for serving internal customers is to assign staff 100% to either customers and/or an issue/topic

This benchmarking research drew participation from executives from 26 leading biopharmaceutical, healthcare, and medical device companies. The full 61-page report contains more than 100 benchmark metrics and 20 executive narratives, providing communications executives with organizational models and trends and insights about structure, staffing and investment levels.

To learn more about this report, download a complimentary excerpt at http://www3.best-in-class.com/rr1094.htm.

For more information on other recent primary research studies, contact us at 919.403.0251 or visit our website at bestpractices@best-in-class.com.

ABOUT BEST PRACTICES, LLCBest Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

SOURCE Best Practices, LLC

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs